Viewing Study NCT01767857


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-01-04 @ 11:49 AM
Study NCT ID: NCT01767857
Status: TERMINATED
Last Update Posted: 2021-06-29
First Post: 2013-01-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Sponsor: Janssen Research & Development, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-03-31
Start Date Type: ACTUAL
Primary Completion Date: 2017-06-30
Primary Completion Date Type: ACTUAL
Completion Date: 2017-06-30
Completion Date Type: ACTUAL
First Submit Date: 2013-01-08
First Submit QC Date: None
Study First Post Date: 2013-01-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-04-22
Results First Submit QC Date: None
Results First Post Date: 2021-06-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-06-28
Last Update Post Date: 2021-06-29
Last Update Post Date Type: ACTUAL